Back to search

National and Kapodistrian University of Athens

Ο ρόλος των αιμοποιητικών κυτοκινών SCF, IL-3, GM-CSF και M-CSF στον καρκίνο του παγκρέατος

Abstract

dc:description

Background: Pancreatic cancer is one of the most aggressive malignancies of thegastrointestinal tract with extremely poor prognosis. The low survival rates ofpancreatic cancer patients reflect the fact that this neoplasm is usually diagnosed at anincurable stage. In an attempt to improve pancreatic cancer prognosis, a large numberof candidate tumor markers have been studied during the last years but withoutcontributing in its early diagnosis. However, the results of studies presenting thepositive impact of hematopoietic cytokines in the proliferation of cancer cells andtheir modified levels in the serum of cancer patients are hopeful.In the present study we estimated the diagnostic ability of hematopoietic cytokinesSCF, IL-3, GM-CSF and M-CSF in the pancreatic and ampullary cancer and wecorrelated them with clinical, laboratory and histological parameters of the disease.Moreover, we determined the role of hematopoietic cytokines in the patients’survival.Materials-methods: In the present study, the serum levels of hematopoieticcytokines SCF, M-CSF, GM-CSF and IL-3 were estimated in 40 pancreatic andampullary cancer patients (22 men and 18 women; mean age, 64.5 years; age range,43-80 years). None of the patients had received chemotherapy or radiotherapy prior tosample collection and the diagnosis of malignancy for all of them was histologicallyestablished. Τhe control group comprised 40 healthy volunteers. Venous bloodsamples were collected preoperatively. Then, they were allowed to clot at roomtemperature for 30 minutes before being centrifuged in order to obtain serum samplesthat were immediately stored at -80οC until assayed. Serum levels of hematopoieticcytokines were measured using ELISA. The classical tumor markers, such ascarbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) were alsomeasured in both groups. The next step was the statistical analysis of the results. Thediscriminating ability of the hematopoietic cytokines and the tumor markers wasestimated by calculating diagnostic sensitivity and specificity, positive and negativepredictive value and receiver operating characteristic (ROC) curve. We compared thediagnostic abilities of hematopoietic cytokines and their combinations. Concentrationsof hematopoietic cytokines, CA 19-9 and CEA were correlated with each other andwith parameters of the disease, such as the tumor location in the pancreas or theampulla, the cancer stage and the symptoms of the patients. Finally, we determined the impact of cytokines, CA 19-9 and CEA on the survival of the patients withunivariate and multivariate analyses.Results: The SCF and IL-3 levels were significantly lower and the M-CSF levelssignificantly higher in the cancer patients than in the healthy subjects. By contrast,serum levels of GM-CSF did not differ significantly in these two groups. The areaunder the ROC curve of M-CSF (0.76) was greater than those of SCF (0.70) and IL-3(0.65). Of all the possible combinations among the tested cytokines, only the additionof M-CSF to SCF significantly increased the diagnostic ability. The diagnosticsensitivity of the combined use of these two cytokines reached 97.5%. Thiscombination was also found to have equal discriminative ability when compared toCA 19-9, while the combination of SCF and M-CSF with CA 19-9 did not improvesignificantly the diagnostic ability of CA 19-9.In the cancer patient’s group there were also significant positive correlationbetween the serum levels of CEA and M-CSF. However, the cytokines studied did notcorrelate significantly with parameters of the disease, such as tumor location in thepancreas or the ampulla, cancer stage and the patients’ symptoms. Univariate analysisrevealed that only the levels of IL-3 correlated significantly with the survival ofpatients. However, the multivariate analysis that also included age, gender and stageshowed that IL-3 is not an independent prognostic factor for the survival of pancreaticand ampullary cancer patients.Conclusions: The findings of this study suggest that the hematopoietic cytokinesSCF, M-CSF, GM-CSF and IL-3 do not differ significantly in relation to the tumorlocation in the pancreas or the ampulla, the cancer stage, the clinical features of thedisease and the survival of patients. Nevertheless, the fact that M-CSF and SCF andespecially their combination can reliable discriminate patients with pancreatic andampullary cancer from healthy controls may be the stimulus for further study in largerseries of patients in order to evaluate their clinical usefulness as tumor markers, andthus contribute in earlier detection of pancreatic cancer and to the improvement of thepatients’ survival.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2012

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Vasiliadis, Georgios
  • Βασιλειάδης, Γεώργιος

Subjects

dc:subject × 20

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/29653

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Vasiliadis, Georgios; Βασιλειάδης, Γεώργιος. Ο ρόλος των αιμοποιητικών κυτοκινών SCF, IL-3, GM-CSF και M-CSF στον καρκίνο του παγκρέατος. National and Kapodistrian University of Athens, 2012. http://hdl.handle.net/10442/hedi/29653